Rapid detection of Vancomycin-Resistant Enterococci (VRE) in rectal samples from patients admitted to intensive care units by d'Azevedo, Pedro Alves et al.
www.bjid.com.br
BJID 2009; 13 (August) 289
Received on 12 May 2009; revised 19 July 2009.
Address for correspondence: Dr. Pedro A. d’ Azevedo. Rua Sarmento
Leite 245/204. Porto Alegre, RS, Brazil. Zip Code 90050-170. Phone:
+55-51-33038740. Fax: +55-51-33039000. Email:
pedro_dazevedo@yahoo.com.br. Financial support: CNPq, LEMC,
UFCSPA.
The Brazilian Journal of Infectious Diseases       2009;13(4):289-293.
© 2009 by The Brazilian Journal of Infectious Diseases and Contexto
Publishing. All rights reserved.
Rapid Detection of Vancomycin-Resistant Enterococci (VRE) in Rectal Samples from Patients
Admitted to Intensive Care Units
Pedro Alves d’Azevedo1,3, Kelly Aline de Souza Santiago1, Guilherme Henrique Campos Furtado2, Diego Batista Xavier4, Antonio
Carlos Campos Pignatari1 and Ricardo Titze-de-Almeida4
1Laboratório Especial de Microbiologia Clínica - LEMC/ALERTA, Universidade Federal de São Paulo - UNIFESP; 2Comissão de Epidemiologia
Hospitalar, Universidade Federal de São Paulo - UNIFESP; 3Laboratório de Cocos Gram-positivos, Universidade Federal de Ciências da Saúde
de Porto Alegre - UFCSPA; 4Laboratório de Microbiologia Molecular e Biotecnologia, Universidade de Brasília - MMB/UnB; Brazil.
The reduction in time required to identify vancomycin-resistant enterococci (VRE) has gained increased importance
during hospital outbreaks. In the present study, we implemented a laboratory protocol to speed up the VRE screening
from rectal samples. The protocol combines a medium for selective VRE isolation (VREBAC®, Probac, São Paulo)
and a multiplex PCR for detection and identification of vanA and vanB resistance genes. The screening performance
was analyzed in 114 specimens collected from four intensive care units. The swabs were collected at two periods: (1)
during a VRE outbreak (February 2006, n=83 patients) and (2) at the post-outbreak period, after adoption of
infection control measures (June 2006, n=31 patients). Forty-one/83 VRE (49.4%) and 3/31(9.7%) VRE were found at
the first and second period, respectively. All isolates harbored the vanA gene. In both periods, detection of the gene
vanA parallels to the minimum inhibitory concentration values of >256 µg/mL and >48 µg/mL for vancomycin and
teicoplanin, respectively. Multiplex PCR and conventional methods agreed in 90.2% for enterococci identification.
Besides this accuracy, we also found a remarkable reduction in time to obtain results. Detection of enterococcal
species and identification of vancomycin resistance genes were ready in 29.5 hours, in comparison to 72 hours
needed by the conventional methods. In conclusion, our protocol identified properly and rapidly enterococci species
and vancomycin-resistance genes. The results strongly encourage its adoption by microbiology laboratories for VRE
screenning in rectal samples.
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Vancomycin-resistant enterococci (VRE) have shown a
remarkable ability to spread during hospital outbreaks [1,2].
Specific control measures need the proper identification of
individuals colonized by VRE through surveillance cultures
[3,4]. The screening for VRE in rectal samples involves the
use of selective isolation media, like the bile esculin azide agar
with vancomycin 6 µg/mL [5]. Complementary tests to identify
the genus Enterococcus and to confirm the resistance
phenotype are required for conclusive results. Also, the intrinsic
vanC-type species E. casseliflavus and E. gallinarum should
be distinguished from the other species that carry the high-
level vancomycin-resistance genes vanA or vanB [6].
Biochemical tests for identification are time-consuming,
expensive and they are sometimes inconclusive. Conventional
protocols to detect vancomycin resistance as the disk diffusion
test, Etest, and broth microdilution are time-consuming as well
[7]. The automated methods also have some drawbacks. They
need expensive equipments and materials and are highly
accurate only for E. faecalis and E. faecium identification [8,9].
Until recently, molecular biology techniques such as the
polymerase chain reaction (PCR) were restricting to university
laboratories. However, those equipments had become cheaper
and various reagent kits are commercially available. Nowadays
clinical laboratories have introduced the PCR technique for
routine diagnostic testing [10]. Thus, rapid and accurate methods
to identify microbial species, with low cost and applicable to
routine laboratory practices have been developed. The present
study implemented a rapid method to detect VRE in rectal swabs
from ICU patients by using the selective VREBAC® medium
and a multiplex PCR scheme that identify enterococci species
and vancomycin-resistance genes.
Materials and Methods
Hospital Setting and Study Design
We examined rectal samples from intensive care units
(ICUs) from São Paulo Hospital, a 700-bed university affiliated
hospital in São Paulo, Brazil. The specimens were collected
from all eligible patients at four ICUs (Medical, Medical-
surgical, Pneumonology, and Adult Emergency). Our study
adopted the following inclusion criteria for swab collection:
long-stay in hospital; previous antimicrobial therapy (mainly
vancomycin); severity of illness; imunossupression; previous
abdominal or cardiothoracic surgery, and invasive procedures.
Eighty-three specimens were examined for the presence of
VRE at the first period (during the outbreak, February, 2006).
Thirty-one specimens were examined at the second period
(the post-outbreak period, June, 2006). At the later period, we
measured the time spent for each activity from the sample
collection until species and resistance determination.
Specimen Collection and Broth Cultures
The specimens were collected by nurses according to
Infection Control Committee protocols. Briefly each swab was
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carefully introduced in the anal sphincter region (1 – 5 cm)
and gently rotated. Immediately after, it was immersed in saline
solution (0.9%, 5mL) and transported to the microbiology
laboratory. In the laboratory this diluted faecal samples were
cultured in all three VREBAC® media. Medium I contained
agar azide and the selective antimicrobials aztreonam,
polymyxin B and amphotericin B. The medium II contained
vancomycin 6µg/mL. Medium III had the same medium II
antimicrobial and a chromogenic marker (Chromagar
Orientation®) [11]. VREBAC® laminocultures were incubated
at 35°C for 18 -24 hours.
Species Identification by Conventional Methods
To identify the genus Enterococcus, we used the following
phenotypic tests: catalase, NaCl 6.5% broth, agar bile esculin
azide, and L-pyrrolidonyl-β-naphthylamide hydrolysis (PYR
test). The biochemical tests used to identify enterococci
species was Purple Broth Base (Difco, Detroit, USA)
supplemented with arabinose, MGP (Metil-α-D-
glycopiranoside), arginine, mannitol, sorbitol, sorbose and
raffinose. Motility and pigmentation were also determined [12].
Multiplex Polymerase Chain Reaction Scheme
We used a multiplex PCR scheme that identifies the species
E. faecalis, E. faecium, E. gallinarum (vanC1), and E.
casseliflavus (vanC2/3). This method also detects, in the same
reaction, the resistance genes vanA and vanB (Table 1). The
primer concentrations previously adjusted to provide easily
distinguished bands were ddlE. faecalis, ddlE. faecium, E. gallinarum-
vanC1, E. casseliflavus-vanC2/3 (18 pmol of each primer),
vanA (3 pmol of each primer), and vanB (2 pmol of each primer)
[13]. For each PCR reaction, 5 – 10 colonies were picked up
from the chromogenic medium II. The PCR mixture contained
the primers and the following reagents: Taq Buffer 1X, 3mM
of MgCl2, 0.25mM of each dNTP, and 2U of Taq DNA
polimerase. The amplification cycles were: initial preheating
step at 94° for 2 min; initial denaturation step at 94°C for 5 min;
30 cycles of amplification (denaturation 94°C for 1 min,
annealing at 55°C for 1 min, and extension at 72°C for 2 min);
and a final extension at 72°C for 5 min.
The PCR products were electrophoresed through a 1%
agarose gel stained with ethidium bromide for 40 min at 60V
and photographed under UV light.
Vancomycin and Teicoplanin Susceptibility
We determined the antimicrobial susceptibility to
vancomycin (30µg) and teicoplanin (30µg) (Oxoid,
Basingstoke, UK) using the disk diffusion method (Kirby-
Bauer), according to the NCCLS guidelines [14]. The plates
were incubated at 35°C for 18 - 24 h. The resistant isolates
were submitted to E-test® according to the manufacturer
recommendations to determine their minimal inhibitory
concentration (MIC) to vancomycin and teicoplanin. The
quality control strains used in our study were ATCC E. faecalis
29.212 and E.coli 24.922.
Results
Species Identification and Vancomycin Resistance Results
We first analyzed the colony growing in each VREBAC®
laminoculture medium I, II, and III. At the first time point
(during the outbreak), all enterococci isolates (n=83, 100%)
grew in the PROBAC® medium I. From them, 18 (21.7%) isolates
grew only in this medium and they showed susceptibility to
vancomycin. The medium II, which contained vancomycin
6µg/mL, showed a lower number of positive growing (n=65,
78.3%). Six vancomycin susceptible enterococci (VSE)
surpassed the antimicrobial inhibitory effects and grew in this
media. The chromogenic and selective medium III identified
59 positive isolates (71.1%). Enterococci isolates were easily
distinguished from the other microbial species owing to the
light green coloration of their colonies
All isolates with positive growing in all three VREBAC®
media (n=59) were selected for the following confirmatory tests:
identification of the genus Enterococcus, resistance to
vancomycin and multiplex PCR. Nine of the 59 isolates (15.2%)
showed susceptibility to vancomycin in the disk diffusion
test, thus they were false positive VRE; all of them showed a
lower number of colonies (2 - 6) in the medium III.
The multiplex PCR identified the species E. faecium (n=20;
48.8%) and E. faecalis (n=21; 51.2%). They were all positive for
the gene vanA. The rate of agreement between PCR and
conventional biochemical tests was 90.2%. The divergent results
occurred for 4 isolates (9.8%) which had the E. faecalis ddl gene
amplified by PCR but showed E. faecium biochemical profiles.
At the second period, we analyzed 31 specimens. From
them, only 4 isolates grew in the chromogenic medium III.
Conventional biochemical tests and PCR identified the species
E. faecium. Three of them carried the vanA gene. The false
positive VRE also showed a reduced number of colonies (n=3)
in the medium III.
Our results showed that the selective and chromogenic
medium III provided the best accurate outcome for the
presumptive diagnostic of VRE. With regard to vancomycin
resistance, the identification of the vanA gene by the multiplex
PCR was consistent with to the disk diffusion testing findings.
In addition, this VanA genotype agreed with the MIC values
determined for vancomycin (>256 µg/mL) and teicoplanin (>48
µg/mL) by Etest method.
Time to Obtain Results
The proposed protocol for VRE screening from rectal
samples was able to reduce the time spent to identify species
and vancomycin resistance. The protocol consumed 29.5
hours for all the laboratorial steps from the specimen collection
to the final result (Table 2). We identified two time-consuming
activities among the procedures grouped in the step 1, the 5.5
hours between the rectal swab collection and the VREBAC®
culture. They were the time to deliver the swabs to the
laboratory and further registration (3h) and the period of
incubation in saline solution (2h). The second step for VRE
screening comprised the VREBAC® culture procedures. The
VREBAC® Plus PCR for Rapid VRE Screening
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Table 1. Oligodeoxynucleotide primers
Table 2. Time for each activity from the VRE screening protocol
selective chromogenic medium III contributed to shorten the
time for obtainining the results, enabling to visualize
presumptive VRE colonies at 18 hours. Additionally the
multiplex PCR also contributed to reduce the time to obtain
results. The method was able to identify VRE species and
vancomycin resistance genes in 4.8 work hours.
Discussion
Vancomycin-resistant enterococci are infectious agents
with remarkable ability to spread and cause hospital outbreaks.
The most commonly reported risk factors for VRE infection are
long stay in hospital, use of vancomycin and third-generation
cephalosporins, and chronic dialysis [15,16,17]. Patients
chronically admitted to ICU are at high risk for colonization and
outbreaks commonly occur in such hospital wards [1].
In our study, we found a high rate of VRE carriage (49.4%)
during the outbreak occurred at the ICUs of São Paulo
Hospital.
The VRE prevalence in 126 adult ICUs from 60 US hospitals
enrolled in the National Nosocomial Infections Surveillance
(NNIS) was extensively analyzed [18]. The prevalence rate
varied among the hospitals (0 – 59%) and was higher at major
teaching centers or larger hospitals (with > 500 beds), similar
to our hospital.
Our study identified a great decrease in the number of
positive VRE specimens from 49.4% to 9.7% after adoption of
infection control measures. The screening protocol adequately
identified VRE isolates during the outbreak, when the bacterial
colonization is higher. Furthermore, the same protocol was
sensitive to detect VRE at lower prevalence rates in the post-
VREBAC® Plus PCR for Rapid VRE Screening
Amplified gene Sequence (5’ - 3’) a Amplicon size (bp)b Reference
ddlE. faecalis F: ATCAAGTACAGTTAGTCT
R: ACGATTCAAAGCTAACTG 941 21
ddlE. faecium F: TAGAGACATTGAATATGCC
R: TCGAATGTGCTACAATC 550 21
E. gallinarum (vanC1) F: GGTATCAAGGAAACCTC
R: CTTCCGCCATCATAGCT 822 21
E. casseliflavus (vanC2/3) F: CTCCTACGATTCTCTTG
R: CGAGCAAGACCTTTAAG 439 21
vanA F: GGGAAAACGACAATTGC
R: GTACAATGCGGCCGTTA 732 21
vanB F: ACCTACCCTGTCTTTGTGAA
R: AATGTCTGCTGGAACGATA 300 24
aF, sense primer; R, antisense primer. bSize of the amplified gene for enterococci identification and vancomycin resistance.
Activities Time
Step 1. Specimens collection and incubation in saline
1.1 Collection of swabs in the ICUs 40’
1.2 Time to deliver the samples to the microbiology laboratory 2.3 h
1.3 Registration of samples 30’
1.4 Swab incubation in saline solution 2 h
Subtotal 5.5h
Step 2. VREBAC® culture
2.1 Culture in VREBAC® media 1 h
2.2 Incubation of the VREBAC® media 18 h
2.3 Selection of presumptive VRE isolates 10’
Subtotal 19.2h
Step 3. PCR reaction and electrophoresis
3.1 Transport of VREBAC® to the molecular biology laboratory 10’
3.2 Preparation of the PCR reactions 40’
3.3 PCR amplification cycles 3 h
3.4 Agarose gel preparation 15’
3.5 Electrophoresis 40’
Subtotal 4.8h
Total time 29.5 h
www.bjid.com.br
292 BJID 2009; 13 (August)
outbreak period. High sensitivity would be important to detect
epidemic strains during non-outbreak periods or to conduct
surveillance studies in non-ICU hospital wards. Interventions
aimed to reduce the VRE prevalence in non-ICU areas are
valuable to diminish the risk of VRE colonization in ICU [18].
The isolates showed different ability to growth in each
VREBAC® laminoculture media I, II, and III. The medium I
contains selective antimicrobials (aztreonam, polymyxin B, and
anfotericin B) that suppress the overgrowth of various species
from the intestinal microbiota. However, our group and others
have observed that some nonenterococcal species
(Pseudomonas, Klebsiella, Candida, and Streptococcus)
surpass the inhibitory effects and grow in this selective media
[5]. Thus, we pre-incubated the rectal swab in 5mL of 0.9%
saline solution for two hours before VREBAC® culture to reduce
the growing of false positive isolates. With regard to medium II,
six vancomycin susceptible enterococci surpassed the
inhibitory effects of vancomycin 6µg/mL. Previous study, using
media contained vancomycin 6µg/mL also found the growing
of vancomycin-susceptible E. faecium and E. faecalis [19].
The use of chromogenic medium has provided satisfactory
results for VRE screening directly from faecal samples. In our
study, the chromogenic medium III allowed to distinguish
enterococci from other species owing to the typical light green
coloration. In this chromogenic VRE selective medium, 59
isolates (71.1%) showed positive growing. In a recent study,
the authors tested another chromogenic media named chromID
VRE (Biomérieux, Marcy-l’Etoile, France). This media was able
to select for and distinguish between vancomycin-resistant
E. faecalis and vancomycin-resistant E. faecium [20]. This
valuable discriminatory property is still not provided by the
VREBAC® medium. However, the species E. faecium and E.
faecalis were rapidly identified (4.8 work hours) by our
multiplex PCR scheme. Our method may distinguish, in
addition, the VanA-, VanB-, and VanC-resistance
genotypes, a feature still not provided by any chromogenic
medium.
Various PCR protocols have been described to identify
enterococci species and to detect vancomycin-resistance
genotypes [7,21,22,23]. The method used in our study
allows the simultaneous identification of E. faecium, E.
faecalis, E. casseliflavus, and E. gallinarum sequences,
as well as the vancomycin-resistant genes vanA and vanB
in one unique reaction [13]. The scheme used primers
previously described and provided easily visualized bands
after agarose gel electrophoresis [21,24]. It also reduced
the time usually spent for DNA extraction because the colonies
are picked up directly from the plate to the PCR mixture. The
rate of agreement between this PCR scheme and the
conventional biochemical assays was high for all species
tested, eg., E. faecalis (95%), E. faecium (95%), E. gallinarum
(100%) and E. casseliflavus (100%) [13]. In the present study,
only 4 isolates (9.8%) showed discordance between PCR and
the biochemical testing. As far as we know, the present study
was the first to test this PCR scheme during a VRE outbreak.
Regarding to resistance genes, all E. faecium and E. faecalis
isolates carried the vanA gene. This high-level of vancomycin
resistance was also found in both E. faecalis and E. faecium
isolated from patients from other Brazilian hospital, during
the first Brazilian VanA outbreak [24].
The rapid identification of VRE is highly valuable during
hospital outbreaks [4,16]. Thus, we carefully evaluated the time
spent in each VRE screening activity of our protocol. We
identified a delay of 2.8 hours between the swab collection
and the specimen incubation in saline solution. Such activity
should consume no more than 30 minutes (Table 2, items 1.2
and 1.3). The incubation in saline should also be shortened
to 1 hour without compromising its inhibitory action (item
1.4). Finally, whether the individuals responsible for PCR
were previously notified when the VREBAC culture was
ready, they could left the PCR mixture prepared, which would
save forty minutes (Table 2, item 3.2). Also, the agarose gel
preparation may occur during the 3h amplification cycles.
Thus, a better planning and reinforcement on the role of
each participant would save at least 4.2 hours. The final
screening report on the species and vancomycin resistance
genes would be provided in 25.3 hours. Previous
publications have also described rapid protocols for VRE
screening. The use of real-time PCR directly from the rectal
swab provided results in 4 – 5 hours but the sensitivity was
lower in comparison with the cultured samples [25]. In addition,
the high cost of the real-time PCR equipment is incompatible
with the general microbiology laboratories.
Conclusion
The present study evaluated a protocol for VRE screenning
in rectal samples from patients admitted to ICU. It employed
the selective medium VREBAC® and the multiplex PCR allowing
reporting enterococci species and vancomycin resistance
genes in up to 29.5 hours. The method showed sensitivity to
detect VRE in high and low prevalence rates. It provided highly
concordant results compared to conventional biochemical and
susceptibility testing. The results found in our study
encourage microbiology laboratories to adopt this rapid
protocol for VRE screening during hospital outbreaks.
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